Evidence map›Paper›PMID 27990297›Full record

ArticleCell discovery2016

HnRNPA2 is a novel histone acetyltransferase that mediates mitochondrial stress-induced nuclear gene expression.

Manti Guha, Satish Srinivasan, Kip Guja, Edison Mejia, Miguel Garcia-Diaz, F Brad Johnson, Gordon Ruthel, Brett A Kaufman, Eric F Rappaport, M Rebecca Glineburg and 7 more

Erratum issuedAbstract read
In one paragraph

Article in Cell discovery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. The HNRNPA2B1-MST1R-Akt axis contributes to epithelial-to-mesenchymal transition in head and neck cancer.Laboratory investigation; a journal of technical methods and pathology · 2020
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Esophageal 3D organoids ofOncotarget · 2019
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Manti GuhaDepartment of Biomedical Sciences & Mari Lowe Center for Comparative Oncology, School of Veterinary Medicine, University of Pennsylvania , Philadelphia, PA, USA.
Satish SrinivasanDepartment of Biomedical Sciences & Mari Lowe Center for Comparative Oncology, School of Veterinary Medicine, University of Pennsylvania , Philadelphia, PA, USA.
Kip GujaDepartment of Pharmacological Sciences, Stony Brook University , Stony Brook, NY, USA.
Edison MejiaDepartment of Pharmacological Sciences, Stony Brook University , Stony Brook, NY, USA.
Miguel Garcia-DiazDepartment of Pharmacological Sciences, Stony Brook University , Stony Brook, NY, USA.
F Brad JohnsonDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA, USA.
Gordon RuthelPenn Vet Imaging Core, School of Veterinary Medicine, University of Pennsylvania , Philadelphia, PA, USA.
Brett A KaufmanVascular Medicine Institute, University of Pittsburg , Pittsburgh, PA, USA.
Eric F RappaportNucleic Acid/Protein Core Facility, Children's Hospital of Philadelphia Research Institute , Philadelphia, PA, USA.
M Rebecca GlineburgDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA, USA.
Ji-Kang FangDepartment of Biomedical Sciences & Mari Lowe Center for Comparative Oncology, School of Veterinary Medicine, University of Pennsylvania , Philadelphia, PA, USA.
Andres J Klein-Szanto
Andres Klein Szanto *Histopathology Facility, Fox Chase Cancer Center, Temple University , Philadelphia, PA, USA.
Hiroshi NakagawaDepartment of Gastroenterology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA, USA.
Jeelan BashaTranscription and Disease Laboratory, Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research , Jakkur , Bangalore, India.
Tapas KunduTranscription and Disease Laboratory, Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research , Jakkur , Bangalore, India.
Narayan G AvadhaniDepartment of Biomedical Sciences & Mari Lowe Center for Comparative Oncology, School of Veterinary Medicine, University of Pennsylvania , Philadelphia, PA, USA.

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
Transformed Esophageal Epithelial Cells and the Tumor MicroenvironmentP01CA098101 · NCI · UNIVERSITY OF PENNSYLVANIA · PI NAKAGAWA, HIROSHI · 2003 to 2023
$31.7M
STRUCTURAL BASIS FOR EPIGENETICS IN AGING AND LONGEVITYP01AG031862 · NIA · WISTAR INSTITUTE · PI BERGER, SHELLEY L · 2008 to 2022
$28.3M
Role of Mitochondria-Targeted CYP2D6 in Chemical ToxicityR01GM034883 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI AVADHANI, NARAYAN G · 1985 to 2018
$6.1M
Role of Mitochondrial Respiratory Stress Signaling in Cancer ProgressionR01CA022762 · NCI · UNIVERSITY OF PENNSYLVANIA · PI AVADHANI, NARAYAN G · 1985 to 2013
$3.3M
Ahr and OsteoporosisR01AR067066 · NIAMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI AVADHANI, NARAYAN G, ZAIDI, MONE · 2014 to 2018
$3.3M
Telomere maintenance by Werner syndrome family proteins.R01AG021521 · NIA · UNIVERSITY OF PENNSYLVANIA · PI JOHNSON, F. BRAD · 2004 to 2013
$2.8M
Mechanisms of mitochondrial transcriptionR01GM100021 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI GARCIA-DIAZ, MIGUEL · 2012 to 2016
$1.5M
MITOCHONDRIAL D-LOOP DNA MUTATIONS AND GENE EXPRESSIONR37CA022762 · NCI · UNIVERSITY OF PENNSYLVANIA · PI AVADHANI, NARAYAN G · 1994 to 2002
$299k
Telomere maintenance by Werner syndrome family proteinsR55AG021521 · NIA · UNIVERSITY OF PENNSYLVANIA · PI JOHNSON, FREDERICK BRADLEY · 2003 to 2003
$100k
Characterization of an essential mitochondrial rRNA methyltransferaseF30ES022930 · NIEHS · STATE UNIVERSITY NEW YORK STONY BROOK · PI GUJA, KIP E · 2013 to 2014
$95k
NCI NIH HHS P01 CA098101NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA022762NIAMS NIH HHS R01 AR067066NIA NIH HHS P01 AG031862NIA NIH HHS R01 AG021521NIA NIH HHS R55 AG021521NIEHS NIH HHS F30 ES022930NIGMS NIH HHS R01 GM034883NIGMS NIH HHS R01 GM100021
6 · The paper itself

Abstract

Reduced mitochondrial DNA copy number, mitochondrial DNA mutations or disruption of electron transfer chain complexes induce mitochondria-to-nucleus retrograde signaling, which induces global change in nuclear gene expression ultimately contributing to various human pathologies including cancer. Recent studies suggest that these mitochondrial changes cause transcriptional reprogramming of nuclear genes although the mechanism of this cross talk remains unclear. Here, we provide evidence that mitochondria-to-nucleus retrograde signaling regulates chromatin acetylation and alters nuclear gene expression through the heterogeneous ribonucleoprotein A2 (hnRNAP2). These processes are reversed when mitochondrial DNA content is restored to near normal cell levels. We show that the mitochondrial stress-induced transcription coactivator hnRNAP2 acetylates Lys 8 of H4 through an intrinsic histone lysine acetyltransferase (KAT) activity with Arg 48 and Arg 50 of hnRNAP2 being essential for acetyl-CoA binding and acetyltransferase activity. H4K8 acetylation at the mitochondrial stress-responsive promoters by hnRNAP2 is essential for transcriptional activation. We found that the previously described mitochondria-to-nucleus retrograde signaling-mediated transformation of C2C12 cells caused an increased expression of genes involved in various oncogenic processes, which is retarded in hnRNAP2 silenced or hnRNAP2 KAT mutant cells. Taken together, these data show that altered gene expression by mitochondria-to-nucleus retrograde signaling involves a novel hnRNAP2-dependent epigenetic mechanism that may have a role in cancer and other pathologies.

Indexed as

acetyl-CoA binding domainhistone acetylationhnRNPA2Mitochondrial retrograde signaling (MtRS)mtDNA depletiontelomerase activationtranscriptional coactivator

Identifiers

PMID27990297
PMCPMC5148442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.